I have 20 years of experience, and specialize in the field of tumor immunology and autoimmunity with specific knowledge in the areas of antibody mediated inflammation, cancer vaccines and antitumor antibodies. I have published on such topics as immune inhibitory receptors, Fc receptors, antitumor antibodies, JAK inhibitors and autoimmunity. I have testified on trastuzumab patent, and chimeric antibody patent. I was the first to describe that antibodies mediate inflammation through Fc receptors and that anti tumor antibodies work through selective binding of activating Fc receptors. I described the utility of PTK inhibitors in autoimmune disease. I am a physician and scientist.